Professor Peter Farmer

Professor of Cancer Biomarkers

Contact Details
  • Tel: 0116 223 1821
  • Email: pbf1@le.ac.uk  
  • Office: Cancer Studies and Molecular Medicine, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, PO BOX 65, Leicester LE2 7LX

Education

  • B.A. (Hons), (Chemistry), Oxford.
  • D.Phil., (Chemistry), Oxford.
  • M.A., Oxford. 

Research Interests

Environmental and life-style factors (including diet) are known to play a major role in the causation of cancer and other chronic diseases. Although tobacco smoking is responsible for about 30% of lethal cancers, it has been estimated that 30-50% of cancer deaths in non-smokers might be avoided by changes in life-style. The carcinogens to which we are exposed are normally in the form of complex mixtures (e.g. pollution or dietary sources), and much effort has gone into determining the nature of the most significant carcinogenic components in these mixtures and their mechanisms of action. Such knowledge would enable the development of preventive measures, leading to a reduction in cancer risks for humans. Essential to achieving this aim is the use of biomarkers in the exposed human population. These can be used not only to characterise the chemical nature of the carcinogens involved, but also to identify key biological effects that result from the exposure, and the effectiveness of preventive measures such as chemoprevention. Our objective is to develop biomarkers of exposure, effect and susceptibility to carcinogens, and to apply them to studies in humans, with the overall objective of reducing human exposure to carcinogens, and consequent risk. A complementary approach to cancer prevention in normal populations is through intervention with chemopreventive agents, which delay or prevent cancer progression, and a secondary objective of ours is to use our biomarkers to assess the efficacy of such procedures and guide future clinical trials.

Publications

To view Professor Farmer's publications, please use the link: PubMed Publication Listing.
 

Share this page:

NEWS

Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform

---------------------------------

SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.